These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6109024)

  • 1. Urinary metabolites of timolol from humans and laboratory animals. Syntheses and beta-adrenergic blocking activities.
    Wasson BK; Scheigetz J; Rooney CS; Hall RA; Share NN; VandenHeuvel WJ; Arison BH; Hensens OD; Ellsworth RL; Tocco DJ
    J Med Chem; 1980 Nov; 23(11):1178-84. PubMed ID: 6109024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timolol metabolism in man and laboratory anamals.
    Tocco DJ; Duncan AE; deLuna FA; Smith JL; Walker RW; Vandenheuvel WJ
    Drug Metab Dispos; 1980; 8(4):236-40. PubMed ID: 6105057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological disposition and metabolism of timolol in man and laboratory animals.
    Tocco DJ; Duncan AE; Delauna FA; Hucker HB; Gruber VF; Vandenheuvel WJ
    Drug Metab Dispos; 1975; 3(5):361-70. PubMed ID: 241617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons of beta-adrenergic blocking properties of S- and R-timolol in humans.
    Rotmensch HH; Vlasses PH; Feinberg JA; Abrams WB; Ferguson RK
    J Clin Pharmacol; 1993 Jun; 33(6):544-8. PubMed ID: 8103526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timolol maleate, a new beta-adrenergic receptor blocking agent.
    Hall RA; Robson RD; Share NN
    Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):251-63. PubMed ID: 238479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and beta-adrenergic blocking effects of timolol.
    Mouillé P; Schmitt H; Cheymol G; Gauter E
    Eur J Pharmacol; 1976 Feb; 35(2):235-43. PubMed ID: 2481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of timolol and other adrenergic agents on intraocular pressure in the rabbit.
    Vareilles P; Silverstone D; Plazonnet B; Le Douarec JC; Sears ML; Stone CA
    Invest Ophthalmol Vis Sci; 1977 Nov; 16(11):987-96. PubMed ID: 21145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive and beta-adrenoceptor antagonist action of timolol.
    Simon G; Kiowski W; Julius S
    Clin Pharmacol Ther; 1978 Feb; 23(2):152-7. PubMed ID: 23235
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of talinolol metabolites in urine of man, dog, rat and mouse after oral administration by high-performance liquid chromatography-thermospray tandem mass spectrometry.
    Schupke H; Hempel R; Eckardt R; Kronbach T
    J Mass Spectrom; 1996 Dec; 31(12):1371-81. PubMed ID: 8990520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic and systemic side effects of ocular beta-adrenergic antagonists in anesthetized dogs.
    Svec AL; Strosberg AM
    Invest Ophthalmol Vis Sci; 1986 Mar; 27(3):401-5. PubMed ID: 2869005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological effects of topical timolol in the rabbit eye.
    Bartels SP; Roth HO; Jumblatt MM; Neufeld AH
    Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1189-97. PubMed ID: 6106643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the beta-adrenergic blocking agents propranolol and timolol on canine cardiac refractory periods.
    Jaillon P; Weissenburger J; Heckle J; Cheymol G
    Eur J Pharmacol; 1979 Oct; 58(3):265-71. PubMed ID: 510358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive radioligand binding assay for timolol in plasma.
    Kaila T
    J Pharm Sci; 1991 Mar; 80(3):296-9. PubMed ID: 1675681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions of non-cardiodepressant beta-adrenergic blocking agents in hemorrhagic shock.
    Lefer AM; Lefer DJ; Levin RJ
    Adv Shock Res; 1980; 3():167-74. PubMed ID: 6118024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analysis of plasma kinetics and beta-receptor binding and -blocking activity of timolol following its small intravenous dose.
    Kaila T; Karhuvaara S; Huupponen R; Iisalo E
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):351-7. PubMed ID: 8103764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adrenergic beta-receptor blocking activity of (3-amino-2-hydroxy)propoxy-3, 4-dihydrocarbostyril derivatives in anesthetized dog (author's transl)].
    Nakagawa K; Murakami N; Yoshizaki S; Tominaga M; Mori H
    Yakugaku Zasshi; 1974 May; 94(5):613-6. PubMed ID: 4153735
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative dromotropic activity of timolol and propranolol in anesthetized dogs.
    Jaillon P; Heckle J; Weissenburger J; Cheymol G
    Eur J Pharmacol; 1978 Jan; 47(2):129-39. PubMed ID: 620680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic studies on CS-359, a new beta-adrenergic blocking agent. I. Isolation and identification of the urinary metabolites of CS-359.
    Hayashi R; Okada M; Nakazawa T; Tanaka Y; Shimoji Y
    Chem Pharm Bull (Tokyo); 1975 Jun; 23(6):1173-83. PubMed ID: 241498
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of topical nipradilol and timolol maleate on intraocular pressure, facility of outflow, arterial blood pressure and pulse rate in dogs.
    Maehara S; Ono K; Ito N; Tsuzuki K; Seno T; Yokoyama T; Yamashita K; Izumisawa Y; Kotani T
    Vet Ophthalmol; 2004; 7(3):147-50. PubMed ID: 15091320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-653,328: an ocular hypotensive agent with modest beta receptor blocking activity.
    Sugrue MF; Gautheron P; Grove J; Mallorga P; Viader MP; Baldwin JJ; Ponticello GS; Varga SL
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):776-84. PubMed ID: 2896641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.